Russell K. Portenoy

Russell K. Portenoy's AcademicInfluence.com Rankings

Russell K. Portenoy

Philosophy

#3456

World Rank

#5587

Historical Rank

Logic

#1168

World Rank

#1850

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Russell K. Portenoy's Degrees

Doctorate Medicine New York University

Why Is Russell K. Portenoy Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Russell K. Portenoy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. (1997) (5587)
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. (2009) (2094)
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. (1994) (1400)
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. (2000) (1178)
Defining the clinically important difference in pain outcome measures (2000) (981)
Breakthrough pain: definition, prevalence and characteristics (1990) (901)
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases (1986) (841)
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. (1997) (822)
Breakthrough pain: characteristics and impact in patients with cancer pain (1999) (690)
Oxford Textbook of Palliative Medicine (2011) (649)
An international survey of cancer pain characteristics and syndromes (1999) (600)
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. (1996) (581)
The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions (1990) (579)
Management of cancer pain (1999) (579)
Symptom prevalence, characteristics and distress in a cancer population (1994) (571)
Opioids and the treatment of chronic pain: controversies, current status, and future directions. (2008) (548)
Treatment of cancer pain (2011) (536)
Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. (1990) (515)
Opioid therapy for chronic nonmalignant pain: a review of the critical issues. (1996) (500)
Controlled-release oxycodone for pain in diabetic neuropathy (2003) (490)
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. (2003) (474)
Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. (2005) (471)
The measurement of symptoms in children with cancer. (2000) (428)
Cancer-related fatigue: guidelines for evaluation and management. (1999) (421)
Pain and its persistence in herpes zoster (1996) (389)
Sedation in the Management of Refractory Symptoms: Guidelines for Evaluation and Treatment (1994) (384)
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. (2015) (377)
Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. (2009) (361)
Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®) (2001) (348)
Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. (2016) (335)
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. (2012) (323)
Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects. (2004) (320)
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey (2004) (316)
Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. (2009) (292)
The undertreatment of pain in ambulatory AIDS patients (1996) (288)
Symptom distress and quality of life in patients with advanced congestive heart failure. (2008) (283)
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. (2002) (264)
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study (1999) (250)
Establishing "best practices" for opioid rotation: conclusions of an expert panel. (2009) (247)
Development and testing of a neuropathic pain screening questionnaire: ID Pain (2006) (244)
Chronic opioid therapy in nonmalignant pain. (1990) (242)
Opioid rotation: the science and the limitations of the equianalgesic dose table. (2009) (239)
Individual variability in the response to different opioids: report of five cases (1992) (237)
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue (1997) (230)
Cancer pain. Epidemiology and syndromes (1989) (229)
Pain and depression in patients with newly diagnosed pancreas cancer. (1995) (223)
Adjuvant analgesics in cancer pain management. (2004) (223)
Symptom prevalence, characteristics, and distress in AIDS outpatients. (1999) (218)
Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms (1994) (215)
A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With Cancer (2006) (213)
Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates (1996) (212)
Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. (2004) (210)
Medical oncologists' attitudes and practice in cancer pain management: a national survey. (2011) (209)
Intracerebral haemorrhage: a model for the prediction of outcome. (1987) (203)
A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. (2002) (201)
Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study (2007) (200)
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. (2014) (199)
Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. (1998) (193)
Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration (1995) (190)
Acute herpetic and postherpetic neuralgia: Clinical review and current management (1986) (188)
A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. (2004) (184)
Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias (1990) (182)
Pain syndromes and etiologies in ambulatory AIDS patients (1997) (176)
Principles and Practice of Supportive Oncology (1998) (174)
Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. (2009) (171)
Implementing national standards for cancer pain management: program model and evaluation. (1996) (171)
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect (1992) (169)
Access to care for chronic pain: racial and ethnic differences. (2005) (164)
Headache in Cerebrovascular Disease (1984) (162)
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. (2008) (162)
Transdermal Fentanyl for Cancer Pain Repeated Dose Pharmacokinetics (1993) (161)
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients (1995) (157)
Pain, opioid use, and survival in hospitalized patients with advanced cancer. (1992) (156)
Pain and Aberrant Drug-Related Behaviors in Medically Ill Patients With and Without Histories of Substance Abuse (2006) (149)
Evidence-based review of the literature on intrathecal delivery of pain medication. (2000) (147)
Pain as a predictor of outcome in patients with operable pancreatic carcinoma. (1997) (144)
The management of cancer pain (1999) (135)
Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life (1996) (135)
Treatment of opioid‐induced constipation with oral naloxone: A pilot study (1992) (134)
Current pharmacotherapy of chronic pain. (2000) (133)
The metabolite morphine‐6‐glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function (1992) (133)
Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000. (2000) (130)
Opioid use and survival at the end of life: a survey of a hospice population. (2006) (129)
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms (1994) (129)
The Design of Analgesic Clinical Trials (1991) (128)
Opioid poorly-responsive cancer pain. Part 1: clinical considerations. (2001) (128)
Pain Management by Primary Care Physicians, Pain Physicians, Chiropractors, and Acupuncturists: A National Survey (2010) (126)
Early seizures following intracerebral hemorrhage (1988) (125)
Cancer pain: pathophysiology and syndromes (1992) (125)
Chronic nausea and morphine-6-glucuronide. (1991) (124)
A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (2010) (124)
Current practices in intraspinal therapy--a survey of clinical trends and decision making. (2000) (123)
Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure (1991) (122)
Pain management in patients with pancreatic carcinoma (1996) (120)
Controversies in the long-term management of analgesic therapy in patients with advanced cancer. (1990) (119)
Measurement of QTc in patients receiving chronic methadone therapy. (2005) (118)
Opioid therapy for chronic nonmalignant pain (1996) (114)
Quality of life and survival (1998) (113)
Back pain in the cancer patient (1987) (113)
Proposed classification of herpes zoster pain (1994) (112)
A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. (2000) (109)
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. (1995) (105)
Pharmacokinetic‐pharmacodynamic relationships of methadone infusions in patients with cancer pain (1990) (103)
Constipation in the cancer patient: causes and management. (1987) (102)
Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. (2001) (102)
Principles of opioid use in cancer pain. (2014) (102)
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study* (2007) (101)
Topics in palliative care (1997) (100)
Treatment of pain in methadone-maintained patients. (2000) (100)
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma (1996) (99)
Treatment of opioid-induced constipation with oral naloxone: a pilot study. (1993) (99)
Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. (2001) (98)
Opioid rotation in the management of refractory cancer pain. (2003) (97)
I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. (1986) (95)
l‐Carnitine Supplementation for the Treatment of Fatigue and Depressed Mood in Cancer Patients with Carnitine Deficiency: A Preliminary Analysis (2004) (94)
Determinants of the willingness to endorse assisted suicide. A survey of physicians, nurses, and social workers. (1997) (91)
Quality of life of women with ovarian cancer. (1995) (90)
A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. (2010) (87)
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. (2002) (85)
The impact of a comprehensive evaluation in the management of cancer pain (1991) (85)
Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics. (2010) (84)
Improving end-of-life care: development and pilot-test of a clinical pathway. (2005) (84)
Prevalence of anemia in cancer patients undergoing radiation therapy. (2001) (83)
Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. (1999) (83)
Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study. (2006) (81)
Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. (2006) (81)
American Academy of Pediatrics Report of the Subcommittee on Assessment and Methodologic Issues in the Management of Pain in Childhood Cancer. (1990) (80)
Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. (2008) (78)
Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. (2005) (77)
Tolerance to opioid analgesics: clinical aspects. (1994) (75)
Delirium as a contributing factor to "crescendo" pain: three case reports. (1994) (73)
The use of corticosteroids in the treatment of symptoms associated with cancer. (1988) (72)
Cancer pain management current strategy (1993) (72)
Breakthrough cancer pain: twenty-five years of study (2016) (72)
Opioid Therapy for Chronic Nonmalignant Pain: Clinicians' Perspective (1996) (70)
Pain management and chemical dependency. Evolving perspectives. (1997) (69)
Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy (1992) (67)
Pain management : theory and practice (1996) (66)
Chronic morphine therapy for cancer pain (1991) (65)
Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. (2001) (64)
Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life. (2010) (63)
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. (2007) (62)
Identification of epidural neoplasm. Radiography and bone scintigraphy in the symptomatic and asymptomatic spine (1989) (62)
Pain and quality of life: clinical issues and implications for research. (1990) (60)
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. (2005) (60)
L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. (2009) (60)
Breakthrough pain: definition and management. (1989) (59)
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. (1994) (57)
Memorial Symptom Assessment Scale (2004) (57)
Cancer-related fatigue: An immense problem. (2000) (57)
Systemic local anesthetics in pain control. (1991) (57)
Acquired immune deficiency syndrome and multiple tract degeneration in a homosexual man (1984) (55)
Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction. (1997) (55)
Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients. (2010) (54)
Prevalence and Characteristics of Breakthrough Pain in Opioid-Treated Patients With Chronic Noncancer Pain (2006) (54)
U.S. board-certified pain physician practices: uniformity and census data of their locations. (2007) (54)
Epidemiology of pain among outpatients in methadone maintenance treatment programs. (2013) (53)
Development of a brief assessment scale for caregivers of the medically ill. (2005) (52)
Management of common opioid side effects during long-term therapy of cancer pain. (1994) (52)
Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain. (2002) (51)
Advances in cancer pain management. (2002) (51)
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis (2004) (49)
Cancer pain : assessment and management (2003) (48)
Cancer Pain Syndromes. (2018) (48)
A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease (2013) (47)
Treatment of temporal variations in chronic cancer pain. (1997) (47)
Neuropathic cancer pain: the role of adjuvant analgesics. (2001) (47)
Opioid rotation in the management of refractory cancer pain. (2002) (46)
Practical aspects of pain control in the patient with cancer (1988) (46)
Practical management of non-malignant pain in the elderly. (1988) (44)
Compulsive thalamic self-stimulation: A case with metabolic, electrophysiologic and behavioral correlates (1986) (44)
A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management? (2000) (42)
How well do medical oncologists manage chronic cancer pain? A national survey. (2015) (39)
Large and small fibre type sensory dysfunction in patients with cancer. (1991) (39)
Pharmacologic management of cancer pain. (1995) (39)
Mechanisms of clinical pain. Observations and speculations. (1989) (38)
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol. (2012) (38)
Appropriate use of opioids for persistent non-cancer pain (2004) (37)
Development and validation of a patient needs assessment tool (PNAT) for oncology clinicians. (1996) (37)
Systemic Opioid Therapy for Chronic Cancer Pain (1998) (36)
Familial occurrence of idiopathic normal-pressure hydrocephalus. (1984) (36)
Physician board certification in hospice and palliative medicine. (2000) (35)
Patterns of analgesic prescription and consumption in a university-affiliated community hospital. (1985) (35)
At-Home Transcranial Direct Current Stimulation (tDCS) With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms (2018) (34)
Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain (2004) (34)
Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. (1998) (34)
A model for the treatment of cancer pain. (1986) (34)
Lobar vs thalamic and basal ganglion hemorrhage: clinical and radiographic features (1987) (33)
Spiritual well-being in patients with advanced heart and lung disease (2012) (33)
Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. (1986) (33)
Cancer pain management. (1993) (33)
National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes (2015) (33)
Nurse practitioner-based models of specialist palliative care at home: sustainability and evaluation of feasibility. (2011) (33)
Managing cancer pain poorly responsive to systemic opioid therapy. (1999) (33)
Ecological Momentary Assessment of Smoking Behavior in Persistent Pain Patients (2014) (32)
Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. (1989) (32)
Oral controlled‐release morphine sulfate. Analgesic efficacy and side effects of a 100‐mg tablet in cancer pain patients (1989) (32)
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. (1987) (32)
Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlates. (2011) (31)
Transcranial Direct Current Stimulation (tDCS) Relieved Itching in a Patient With Chronic Neuropathic Pain (2013) (30)
Symptom assessment. (1996) (30)
Continuous intravenous infusion of opioid drugs. (1987) (30)
Subcutaneous opioid infusions at home. (1994) (30)
Clinical analgesic assay of repeated and single doses of heroin and hydromorphone (1990) (28)
A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic pain. (2010) (28)
Web-Based Cognitive Behavior Therapy for Chronic Pain Patients with Aberrant Drug-Related Behavior: Outcomes from a Randomized Controlled Trial (2018) (27)
Issues in Palliative Care Research (2003) (27)
Painful polyneuropathy. (1989) (27)
Adjuvant analgesic agents. (1996) (27)
Pain 2002 - An Updated Review (2002) (26)
Defining Core Competencies for Generalist-Level Palliative Social Work. (2018) (26)
Management of fatigue in the cancer patient. (2002) (26)
Group report: Mechanisms of neuropathic pain following peripheral injury (1991) (25)
The need for an open mind about the treatment of chronic nonmalignant pain (1994) (25)
7.7 The measurement of pain and other symptoms (2009) (25)
The pharmacological management of chronic pain in the paraplegic patient. (1986) (25)
Cancer pain management. (2005) (24)
How to use antidepressants and anticonvulsants as adjuvant analgesics in the treatment of neuropathic cancer pain. (2006) (24)
Optimal pain control in elderly cancer patients. (1987) (24)
Pharmacotherapy of neuropathic pain. (1994) (23)
Continuous infusion of opioid drugs in the treatment of cancer pain: guidelines for use. (1986) (23)
Ethical challenges in the care of patients with serious illness. (2001) (21)
Morphine Infusions at the End of Life: The Pitfalls in Reasoning from Anecdote (1996) (20)
Comprar Oxford Textbook of Palliative Medicine 4Ed | Russell K. Portenoy | 9780199693146 | Oxford University Press (2011) (20)
Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report (2012) (20)
A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer pain (1993) (20)
Substance abuse issues in cancer patients. Part 2: Evaluation and treatment. (1998) (19)
World Health Organization-International Association for the Study of Pain: joint initiatives in Cancer Pain Relief. (1993) (19)
Pain management in the older cancer patient. (1992) (19)
An exploratory study of frequent pain measurement in a cancer clinical trial (1996) (18)
Formal ABMS and ACGME recognition of hospice and palliative medicine expected in 2006. (2006) (17)
Web-based symptom screening in cystic fibrosis patients: A feasibility study. (2016) (16)
Selection of analgesic therapies in rheumatoid arthritis: the role of opioid medications. (1993) (15)
Chronic opioid therapy for nonmalignant pain from models to practice (1992) (14)
[Drug therapy for tumor pain I. Properties of non-opioids and opioids.]. (1994) (13)
Drug-induced prolongation of the QT interval [2] (multiple letters) (2004) (13)
Symptom Distress Among Diverse Patients Referred for Community-Based Palliative Care: Sociodemographic and Medical Correlates. (2017) (13)
Central pain from cerebral abscess (1992) (13)
The physical examination in cancer pain assessment. (1997) (13)
Trajectories of caregiver burden in families of adult cystic fibrosis patients (2017) (12)
Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication (2016) (12)
Infection as a cause of rapidly increasing pain in cancer patients. (1991) (12)
Initial Validation of the Daily Spiritual Experiences Scale in Chinese Immigrants With Cancer Pain. (2016) (12)
Pain management: pharmacological approaches. (1999) (12)
Chronic intractable pain: An atypical presentation of multiple sclerosis (1988) (12)
Epidural air from a bronchopleural‐epidural‐ cutaneous fistula producing reversible myelopathy and radiculopathy symptoms (1994) (11)
Addressing the burden of illness in adults with cystic fibrosis with screening and triage: An early intervention model of palliative care. (2020) (11)
A High-Touch Model of Community-Based Specialist Palliative Care: Latent Class Analysis Identifies Distinct Patient Subgroups. (2016) (11)
Hospice Enrollment After Referral to Community-Based, Specialist-Level Palliative Care: Incidence, Timing, and Predictors. (2016) (11)
Attitudes and Beliefs Towards Advance Care Planning among Underserved Chinese-American Immigrants. (2020) (11)
Managing pain in patients with advanced cancer: the role of neuraxial infusion. (1999) (11)
Determinants of the Wiffingness to Endorse Assisted Suicide (1997) (11)
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017. (2021) (10)
Euthanasia and palliative care (2015) (10)
Quality of Life in Community-Dwelling Chinese American Patients with Cancer Pain (2017) (10)
Variation in symptom distress in underserved Chinese American cancer patients (2015) (10)
Drugs in the treatment of pain: NSAIDS and opioids (1993) (10)
Cancer pain: from curriculum to practice change. (1992) (10)
Methodological Issues in the Design of Analgesic Clinical Trials (2003) (10)
Dynorphin A(1–13) Analgesia in Opioid-Treated Patients with Chronic Pain (1999) (10)
Myths About Controlling Pain (2004) (9)
Guidelines for use of controlled‐release oral morphine in cancer pain management Correlation with clinical experience (1989) (9)
Treating sickle cell pain like cancer pain. (1992) (9)
Treatment of Dyspnea in Cancer Patients (2002) (9)
Controversies in the Long-Term Management of Analgesic Therapy in Patients with Advanced Cancer (1991) (9)
Pharmacologic management of chronic pain (1990) (9)
Understanding the Chameleonic Breakthrough Cancer Pain (2021) (9)
MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice? (2008) (9)
Report from the International Association for the Study of Pain Task Force on cancer pain. (1996) (9)
Pain syndromes in head and neck cancer (1988) (9)
Giving a grand rounds presentation. (2010) (9)
New opioids: expensive distractions or important additions to practice? (2010) (9)
Assessing Decision-Making Capacity in the Setting of Palliative Care Research (2003) (8)
Strategies for limiting the side effects of cancer pain therapy. (1997) (8)
The effect of drug regulation on the management of cancer pain. (1991) (8)
Responding to intractable terminal suffering. (2000) (8)
Enhancing opioid analgesia with NMDA-receptor antagonists: clarifying the clinical importance. A roundtable discussion. (2000) (8)
Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention. (2019) (8)
Drug treatment of pain syndromes. (1987) (8)
Pharmacologic Approaches to the Control of Cancer Pain (1990) (8)
Bilateral burning foot pain: monitoring of pain, sensation, and autonomic function during successful treatment with sympathetic blockade. (1991) (8)
Return to alertness after brain-stem hemorrhage. A case with evoked potential and roentgenographic evidence of bilateral tegmental damage. (1985) (8)
Evaluating the Relationship of Fatigue to Depression and Anxiety in Cancer Patients (2003) (8)
Repurposing Medications for Hospice/Palliative Care Symptom Control Is No Longer Sufficient: A Manifesto for Change. (2017) (7)
Issues in the economic analysis of therapies for cancer pain. (1995) (7)
Publication of papers on assisted suicide and terminal sedation. (2000) (7)
The road to formal recognition: the end is in sight. (2005) (7)
Administration of morphine sulfate extended-release capsules via gastrostomy: dissolution study and case reports. (2007) (7)
Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain. (2006) (7)
Evolving Role of NMDA-Receptor Antagonists in Analgesia (2000) (7)
Postherpetic neuralgia: a workable treatment plan. (1986) (7)
Degree of pain intolerance and adverse outcomes in chronic non-cancer pain patients (2005) (7)
Increased intracranial pressure with normal ventricular size due to superior vena cava obstruction. (1983) (6)
Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity. (2012) (6)
Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain. (2010) (6)
Breakthrough Pain in Cancer Patients: Characteristics, Prevalence, and Treatment (1998) (6)
Epidemiology of Pain in Ambulatory Patients with Lung or Colon Cancer (1991) (6)
Acute herpetic and postherpetic neuralgia: clinical features and management. (1991) (6)
Clinical perspectives on preclinical models of bone pain: Questions and promises (2011) (6)
Intravenous treatment of migraine (2012) (6)
Clinical realities and economic considerations: introduction. (1997) (6)
21 Long term results of primary radiation therapy for squamous cancer of the base of tongue (1996) (6)
Polyradiculopathy in leptomeningeal metastasis: The role of EMG and late response studies (1990) (5)
(777): Pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia: Onset and duration of analgesia in combined analyses of clinical studies (2006) (5)
Review and recommendations Pharmacologic management of neuropathic pain: Evidence-based recommendations (2007) (5)
Creating a shared vision. (2008) (5)
Pharmacokinetic-pharmacodynamic (PK-PD) relationships of methadone and hydromorphone infusions in pain patients (1987) (5)
Hospice Enrollment After Referral to Community-Based, Specialist Palliative Care: Impact of Telephonic Outreach. (2017) (5)
Prevalence of Substance Abuse Disorders in Cancer Patients (1998) (5)
Fentanyl pectin nasal spray (FPNS) with PecSys®: efficacy, tolerability, and onset of action in the treatment of breakthrough cancer pain (BTCP) (2009) (5)
Cancer Pain: Adjuvant analgesic drugs (2003) (5)
Development and validation of the Brief Assessment Scale for Caregivers in Chinese. (2013) (5)
10.1.8 Adjuvant analgesics in pain management (2009) (4)
Response to the letters to the editor by Dr. Du Pen and Ms. A. Williams and by Drs. Arnér and Meyerson (1991) (4)
[Pharmacotherapy of cancer pain : 2. Use of opioids.]. (1995) (4)
(324/1000): A national survey on pain management practices in the United States (2006) (4)
[Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]. (1995) (4)
Therapeutic use of opioids: prescribing and control issues. (1993) (4)
Understanding clinical trials in pain research (2003) (4)
Proceedings #23. A Patient-Tailored Protocol of tDCS Stimulation Paired with Telehealth Support for At-home Symptom Management in Seriously Ill Patients with Multiple Chronic Symptoms (2017) (4)
(312/729): A randomized, placebo-controlled study of fentanyl effervescent buccal tablets for relief of breakthrough pain in opioid-tolerant patients with cancer (2006) (4)
Evaluation of back pain caused by epidural neoplasm. (1993) (4)
Diagnosis of cancer pain syndromes (1990) (4)
Opioids for Chronic Noncancer Pain: The Need for Balance (2014) (4)
78 Detailed quality of life assessment on long term survivors of primary radiation therapy for cancer of the base of tongue (1995) (4)
Adjuvant analgesics in pain management: Part I. (1994) (4)
The influence of race and other factors on the outcome of intracranial surgery for cerebral artery aneurysms. (1984) (4)
Development and Pilot Test of a Culturally Relevant Toolkit to Enhance Advance Care Planning with Chinese American Patients. (2021) (3)
Research in Pediatric Palliative Care (2003) (3)
Prevalence and characteristics of breakthrough pain in patients with chronic noncancer pain (2005) (3)
Fentanyl pectin nasal spray (FPNS) with PecSys®: onset of action, consistency, and acceptability in breakthrough cancer pain (BTCP) (2009) (3)
Controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet (1988) (3)
Are the people who need analgesics getting them? (1986) (3)
Legal and regulatory aspects of opioid treatment: the United States experience (2003) (3)
Research to Improve End-of-Life Care in the United States: Toward a More Behavioral and Ecological Paradigm (2003) (3)
Pain management guidelines: implications for managed care--a roundtable discussion. (1997) (3)
Pharmacotherapy of Cancer PainA Practical Guide. (1993) (3)
Neurostimulation for cognitive enhancement in Alzheimer's disease (the NICE-AD study): a randomized clinical trial. (2021) (3)
Neurological consultation in the management of patients with systemic cancer admitted to a community hospital. (1986) (3)
Transient thermal sympathectomy as a possible mechanism for hypotension after kyphoplasty: a case report. (2013) (3)
Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer. (2019) (3)
Palliative medicine: from paradigm to best practice. (2008) (3)
Studying Desire for Death: Methodological Issues in End-of-Life Research (2003) (3)
Developing an integrated Department of Pain and Palliative Medicine. (2002) (2)
The following letter is in response to dr. Loeb et al.: To the editor (1986) (2)
Chronic Nociceptive Pain Syndromes: Cancer Pain (1997) (2)
Chapter 28 – Neuropathic Pain (2009) (2)
Finding an appropriate dose of fentanyl effervescent buccal tablets for relief of cancer-related breakthrough pain. (2016) (2)
SECTION 20 Education and training in palliative medicine (2009) (2)
Coping with pain in cancer patients (2005) (2)
Long-term safety, tolerability, and acceptability of fentanyl pectin nasal spray in the treatment of breakthrough cancer pain. (2010) (2)
L-carnitine supplementation improves fatigue, mood and sleep in cancer patients with fatigue and carnitine deficiency. (2006) (2)
Management of breakthrough pain (2008) (2)
Cancer Pain: Cancer pain syndromes (2009) (2)
Fatigue in Medical Illness: Research Issues (2003) (2)
Development and Field Test of an Audit Tool and Tracer Methodology for Clinician Assessment of Quality in End-of-Life Care. (2017) (2)
(731): Successful dose finding with fentanyl effervescent buccal tablets: Combined results of open-label titration (2006) (2)
Cancer Pain: Pharmacogenetic considerations in the treatment of cancer pain (2001) (2)
Evidence that the Metabolite, Morphine-6-Glucuronide, Contributes to the Analgesic Effects of Morphine (1991) (2)
Quality improvement for symptom control in underserved Chinese American cancer patients (2010) (2)
Unavailability of narcotic analgesics for ambulatory cancer pain patients in New York city (1984) (2)
Palliative Care Research in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Clinical Trials of Symptomatic Therapies (2003) (2)
TRICYCLIC ANTIDEPRESSANTS FOR CHRONIC PAIN (1984) (2)
Encyclopedia of pain, vol. 1-3 (2007) (2)
Drugs in the treatment of pain (1993) (2)
Quality improvement for symptom control in underserved Chinese cancer patients. (2012) (2)
An exploratory study of frequent pain measurement in a cancer clinical trial. (1997) (2)
The prevalence and burden of cancer symptoms among underserved Chinese American patients. (2012) (2)
Cancer pain management : update on breakthrough pain (1997) (1)
10.7 Skin problems in palliative medicine (2009) (1)
Re: Spinal cord compression in advanced malignancy. (1994) (1)
SECTION 10 The management of common symptoms and disorders (2009) (1)
Statistical approach to measuring analgesic response (1990) (1)
A new validated patient-completed neuropathic pain screening tool for use in the primary care setting (2005) (1)
Pain medicine and drug law enforcement: an important step toward balance. (2005) (1)
Species Dependent Accumulation of Morphine-6-Glucuronide (M-6-G) After Morphine (MOR) Administration (1991) (1)
Costs associated with breakthrough pain in cancer patients: findings from the national breakthrough pain survey (2013) (1)
Pain Control: Using Continuous Infusion with PCA (1999) (1)
Using continuous infusion with PCA. (1999) (1)
Depression in the Terminally Ill: Prevalence and Measurement Issues (2003) (1)
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma (1)
Normal mental state despite bilateral pontine tegmental hemorrhage (1986) (1)
Reply to H. Charalambous et al (2012) (1)
Drug therapy for cancer pain (1990) (1)
A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF FENTANYL EFFERVESCENT BUCCAL TABLETS FOR BREAKTHROUGH PAIN IN OPIOID-TOLERANT PATIENTS WITH CANCER (2011) (1)
The National Breakthrough Pain Survey (NBTPS): assessment of quality-of-life, functioning, and productivity (2011) (1)
Institutional Special Needs Plans and Hospice Enrollment in Nursing Homes: A National Analysis (2019) (1)
10.3 Weight loss in palliative medicine (2009) (1)
Effect of oral methadone on the QTc interval in patients with increased risk for QTc prolongation (2011) (1)
Measurement of, and tools for, pain and other symptoms (2014) (1)
D. Treatment approaches (medical/interventional)Opioids in non-cancer pain: CR-oxycodone for long-term, non-malignant pain treatment: Relationship of pain to continuation of treatment (2004) (1)
Continuous infusion of opioids. (1986) (1)
Race and Ethnicity Do Not Clinically Associate with Quality of Life Among Patients with Chronic Severe Pain in a Federally Qualified Health Center (2018) (1)
Treatment of pain in sickle-cell crisis. (1994) (1)
Unwillingness to fill opioid analgesic prescriptions by local pharmacies. (2000) (1)
Multidimensional Assessment of Dyspnea (2003) (1)
Methadone Maintenance Therapy and Chronic Pain (2003) (1)
A Practical Approach to Using Adjuvant Analgesics in Older Adults (2020) (1)
134) Symptom burden clusters in underserved Chinese American cancer patients (2014) (1)
THE ART OF ONCOLOGY : WHEN THE TUMOR IS NOT THE TARGET Opioid Rotat ion in the Management of Refractory Cancer Pain (2001) (1)
Control of Pathological Pain (1996) (1)
Feasibility and Acceptability of a Pharmacogenomic Decision Support System in Palliative Care. (2021) (1)
Brief Assessment Scale for Caregivers (2018) (1)
Abstracts Fifteenth Annual Meeting of the Society for clinical trials The Westin Galleria Hotel, Houston, Texas May 8–11, 199414A A design for assessing clinical benefit for patients with advanced pancreatic cancer (1994) (1)
Cancer Pain: Cancer Pain (2009) (1)
Symptom distress and symptom clusters in underserved Chinese-American cancer patients. (2014) (1)
Drug-induced prolongation of the QT interval. (2004) (1)
SECTION 15 Psychiatric, psychosocial, and spiritual issues in palliative medicine (2009) (1)
Opinion #2 (2002) (1)
Toward optimal health: the experts discuss chronic pain. Interview by Jodi Godfrey Meisler. (2002) (1)
Assessing Quality of Life in Palliative Care (2003) (1)
SECTION 1 Introduction to the fourth edition: facing the challenges of continuity and change (2009) (1)
A 15-year-old boy with primitive neurectodermal tumor. (1999) (1)
Cancer pain: Assessment and Management, second edition (2009) (1)
Pain Medicine and Drug Law Enforcement (2005) (1)
Prevalence of Psychological Symptoms in Community-Dwelling Chinese American Patients with Chronic Cancer Pain (2021) (1)
Pain due to epidural tumor in cancer patients. Report of two cases and differential diagnosis (1997) (1)
544 A RANDOMIZED, PLACEBO‐CONTROLLED STUDY OF FENTANYL EFFERVESCENT BUCCAL TABLET (FEBT) FOR RELIEF OF BREAKTHROUGH PAIN IN OPIOID‐TREATED PATIENTS WITH CANCER (2006) (1)
L-carnitine supplementation in cancer patients with fatigue and carnitine deficiency. (2004) (1)
Comprar Cancer Pain 2ed | Russell K. Portenoy | 9780521879279 | Cambridge University Press (2009) (1)
Studying Nonpharmacological Interventions for Fatigue (2003) (1)
Letter to the editor Re., repply to R. Sternback (1987) (1)
Current Status of Symptom Measurement in Children (2003) (1)
Research into Nonpharmacological Intervention for Respiratory Problems in Palliative Care (2003) (0)
Corticosteroids in symptom control: The need for careful assessment (1993) (0)
Summary of contents (2009) (0)
HSD10 Medical Cannabis Legalization and Opioid- and Pain- Related Outcomes Among U.S. Patients Newly Diagnosed With Cancer and Receiving Anti-Cancer Treatment (2022) (0)
Drug therapy for cancer pain (1990) (0)
Pain Consult: Continuous Infusion of Opioids (1986) (0)
ADAPTED WITH PERMISSION FROM JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (1986) (0)
SECTION 5 Ethical issues (2009) (0)
THE ART OF ONCOLOGY: WHEN THE TUMOR IS NOT THE TARGET Opioid R otation i n t he M anagement o f R efractory Cancer P ain (2002) (0)
Symptom control in underserved Chinese American cancer patients: a community-based quality improvement intervention (2013) (0)
Influence of response shift on the perception of fatigue in patients with advanced cancer. (2004) (0)
Commentary (Cruciani/Portenoy)—Opioid Rotation in Cancer Patients: Pros and Cons (2005) (0)
JPSM affiliates with the AAHPM. (2009) (0)
Changing Pain Management Practices in Hospitals and Cancer Centers (2003) (0)
Standards for monitoring quality of analgesic treatment of postoperative pain and cancer pain (1990) (0)
Getting Published in the Journal of Palliative Medicine and the Journal of Pain and Symptom Management (P2) (2010) (0)
When the opioid fails: managing the patient with severe neuropathic pain (2003) (0)
Cancer Pain: Plate section (2009) (0)
PAIN RELATED COGNITIONS ASSOCIATED WITH INCREASED PAIN INTENSITY, PSYCHOLOGICAL DISTRESS AND FUNCTIONAL INTERFERENCE IN CANCER PAIN PATIENTS (1998) (0)
Family participation in hospice home care. (1996) (0)
Pain and Quality of Life: Theoretical Aspects (2021) (0)
Cancer pain in children (2003) (0)
10.2 Gastrointestinal symptoms (2009) (0)
Longitudinal Changes in Symptom Distress and Quality-of-Life in Patients with End-Stage Chronic Disease (2010) (0)
Education: professional and lay (2004) (0)
Building definitional consensus in palliative care (2021) (0)
Cancer Pain: PHARMACOLOGICAL TREATMENT (2009) (0)
Recent advances in the treatment of cancer pain. (2010) (0)
Conversation: Russell Portenoy, MD, on Why Inconsistencies Exist—for Now—in the REMS for Different Pain Drugs (2011) (0)
Core concepts in palliative care (2021) (0)
Prospective survey of pain and other symptoms in ovarian cancer (OC) (1990) (0)
Symptoms of Creeping Cancer (1992) (0)
Analgesic use in advanced cancer patients (1988) (0)
Measurement of Constipation (2003) (0)
Nociception: basic principles (2003) (0)
Opioid switching. Authors' reply (2003) (0)
Tumor-Related Nociceptive Pain Syndromes (2012) (0)
(192) Feasibility of monthly web-based screening for pain and symptoms in cystic fibrosis patients. (2016) (0)
Education and training (2019) (0)
Advances in PAIN MANAGEMENT (2008) (0)
Abscesses and thalamic pain (1992) (0)
PROVIDING END-OF-LIFE CARE FOR PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES: EXPERIENCE OF A HOSPICE AGENCY. (2020) (0)
SECTION 2 The worldwide status of palliative care (2009) (0)
Reply to letter to editor (2012) (0)
Prevalence of pain and symptoms among ethnic Chinese cancer patients treated in a community cancer setting (2009) (0)
SECTION 4 The interdisciplinary team (2009) (0)
10.1 The management of pain (2009) (0)
SECTION 11 Issues in specific neoplastic disease (2009) (0)
Misconception about hospice. (2005) (0)
What is measured by the schedule for the evaluation of individual quality of life-direct weighting? (2002) (0)
METHADONE AND HYDROMORPHONE INFUSIONS IN PAIN PATIENTS. (1988) (0)
SECTION 9 Disease-modifying management in advanced cancer (2009) (0)
Pain-related distress among patients referred to a community-based palliative care program (2018) (0)
Eastern Pain Association (1992) (0)
SECTION 14 Geriatric palliative medicine (2009) (0)
The Memorial Pain Assessment Card: Validity and Reliability for Repeated Evaluation of Cancer Pain (1991) (0)
Cancer Symptom Science: The clinical science of cancer pain assessment and management (2010) (0)
Management of Refractory Pain in Palliative Care (430) (2010) (0)
ASPMN backs pain champion: Russell Portenoy. (2013) (0)
Adjuvant analgesics for cancer pain (2012) (0)
Assessment of Novel Therapies for Constipation: Focus on Opioid Analgesics (2003) (0)
Response to S. Mercadante (1991) (0)
Chapter 37 – Adjuvant Analgesics (2009) (0)
Cancer Pain: SPECIAL TOPICS (2003) (0)
SECTION 12 Palliative medicine in non-malignant disease (2009) (0)
Palliative Care in the Terminal Stage of Neurological Diseases (2003) (0)
Opioids: clinical pharmacology (2004) (0)
Risks associated with opioid use. (2013) (0)
5 Chronic Nociceptive Pain Syndromes : Cancer Pain (0)
Opioids in non-cancer pain (2004) (0)
Effect of breakthrough pain on functional status, pain interference, and disability in cancer patients: Findings from the national breakthrough pain survey. (2013) (0)
SECTION 6 Communication and palliative medicine (2009) (0)
Workforce and leadership. (2008) (0)
SECTION 18 Palliative care in the home (2009) (0)
Strengthening communities. (2008) (0)
A 38-year-old man with pancreatic cancer. (1999) (0)
Epidemiology of Cancer Pain and Symptoms among Underserved Ethnic Chinese Patients Treated in a Community Oncology Setting (2010) (0)
36LBA Long-term safety and tolerability of fentanyl pectin nasal spray in opioid-tolerant patients in the treatment of breakthrough cancer pain (2009) (0)
Clinical Section Compulsive Thalamic Self-Stimulation: a Case with Metabolic, Electrophysiologic and Behavioral Correlates ' (1986) (0)
Pain management in patients with pancreatic carcinoma (0)
Methadone Maintenance Therapy and Chronic Pain--Reply (2003) (0)
Cancer Pain: Preface (2009) (0)
Pain in respiratory disease: mechanisms and management (2012) (0)
Prescribing and consumption patterns of analgesic and adjuvant drugs in a major tertiary cancer center (1988) (0)
(885): Pain-catastrophizing in patients with advanced cancer (2006) (0)
Non-Cancer Pain (2007) (0)
A Screening-And-Early-Intervention Palliative Care Model for Cystic Fibrosis Patients: Development and Initial Implementation (S722) (2015) (0)
Abstract #62: Feasibility of tDCS for Symptom Control in Elderly Chronically Ill Nursing Home Residents (2019) (0)
P254 Development of a primary palliative care model that includes a novel approach to address the needs of caregivers of adults with cystic fibrosis - improving life with cystic fibrosis: a primary palliative care partnership (2021) (0)
Other Analgesic Approaches and End-of-Life Care (2010) (0)
Cancer Pain: SYSTEMS OF CARE (2009) (0)
ABSCESSES AND THALAMIC PAIN. REPLY (1992) (0)
Is optimal pain relief at the end of life real relief? (2002) (0)
(247) Attitudes and beliefs about pain management among providers treating an economically-disadvantaged primary care population (2015) (0)
Back pain in the elderly patient. (1993) (0)
Poster 160: Prevalence and Characteristics of Breakthrough Pain in Patients With Chronic Noncancer Pain (2005) (0)
Standards for Monitoring Quality of Analgesic Treatment of Post-operative Pain and Cancer Pain (1991) (0)
Back Pain in the Elderly Patient: Case Commentaries (1993) (0)
Treatment of chronic pain. Possibilities, limitations and long-term follow-up. Edited by M. Mumenthaler, P. A. Van Zwieten, and J. M. Farcot New York, Harwood Academic Publishers, 1990 337 pp, illustrated, $95.00 (hardcover) $63.00 (paper) (1992) (0)
Expanding Access to Community-Based Palliative Care: A Palliative Care in Home Health (PCHH) Model (TH341A) (2017) (0)
Clinical Trials of Antiemetics in the Palliative Care Setting: Research Issues (2003) (0)
Cancer Pain: OTHER INTERVENTIONAL STRATEGIES (2009) (0)
SECTION 13 Paediatric palliative medicine (2009) (0)
Profound Analgesia in a Patient with Cancer Pain: Effect of “Auto-Hypophysectomy” from a Metastasis (1991) (0)
Bilateral Burning Foot Pain: Pain, Sensation, and Autonomic Function During Successful Treatment With Sympathetic Bloc (1991) (0)
Letter to the editor (1984) (0)
THE ROLE OF ELECTROMYOGRAPHIC, NERVE CONDUCTION, AND LATE RESPONSE STUDIES IN LEPTOMENINGEAL METASTASES (1988) (0)
Palliative treatment of last resort and assisted suicide. (2000) (0)
Symptom control in underserved Chinese American cancer patients (2011) (0)
Letters to the Editor (1994) (0)
Cancer Pain: Pain in medical illness: ethical foundations (2003) (0)
Assessment and Management of Pain (2021) (0)
Coyle and colleagues respond (1991) (0)
SECTION 3 The challenge of palliative medicine (2009) (0)
(747): Open label pilot trial of IV ibandronate for complex regional pain syndrome (2007) (0)
Other: Prevalence and impacts of pain in patients with end-stage heart and lung disease (2004) (0)
Management of Cancer Pain with Evidence for Each Strategy (2002) (0)
Cancer Pain: Pain in medical illness: ethical and legal foundations (2009) (0)
Changing Perspectives on Palliative Care (2002) (0)
SECTION 7 Research in palliative medicine (2009) (0)
Changing Palliative Care Practice in Academic Medical Centers (2003) (0)
Brief Assessment Scale for Caregivers--Chinese Version (2018) (0)
Pharmacotherapy of Pain in Populations with Serious Illness: Best Practices and Emerging Issues (P9) (2014) (0)
Poster 159: Prevalence and Characteristics of Breakthrough Pain in Patients With Chronic Back Pain (2005) (0)
Pain 2003 - An Updated Review (2003) (0)
SECTION 19 The terminal phase (2009) (0)
Poster 157 : A New Validated Patient-Completed Neuropathic Pain Screening Tool for Use in the Primary Care Setting (2005) (0)
[The estimation of the i.m. morphine-equivalent in cancer pain treatment with different opioids or different routes of administrations. Practical meaning and limitations.]. (1990) (0)
Validation of a Comprehension Patient Evaluation Scale (CPES) for Cancer Patients: Preliminary Data (1991) (0)
Last rights. (1983) (0)
449 ONSET AND DURATION OF ANALGESIA IN COMBINED ANALYSES OF CLINICAL TRIALS OF PREGABALIN FOR PAINFUL DPN AND PHN (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Russell K. Portenoy?

Russell K. Portenoy is affiliated with the following schools: